Leerink says cancer vaccine win should sustain Merck momentum into fall
Leerink says a cancer vaccine win should sustain Merck momentum into fall, with the note referencing MRNA, BNTX and MRK and supplying no further catalyst details.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.